Comparison between2 Drugs in Lupus Nephritis
NCT04424602 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2022-06-21
Summary
The aim of this work is to study the effect and side effects of the cyclophosphamide versus mycophenolate in lupus nephritis
Conditions
Interventions
- DRUG
-
cyclo phosphamide
500mg vial
- DRUG
-
mycophenolate
500mg film-coated tablets.
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-05
- Primary Completion
- 2021-09-05
- Completion
- 2021-09-09
Countries
- Egypt
Study Locations
More Related Trials
-
Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
NCT02453997 ·Status: COMPLETED
-
Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
NCT00876616 ·Status: COMPLETED ·Phase: NA
-
Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study
NCT00976300 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.
NCT00204022 ·Status: COMPLETED ·Phase: PHASE3
-
Proliferative Lupus Nephritis Treatment With Chloroquine and Hydroxychloroquine
NCT03687905 ·Status: UNKNOWN
-
Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital
NCT04756492 ·Status: UNKNOWN
-
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
NCT00425438 ·Status: TERMINATED ·Phase: PHASE3
-
A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
NCT01689350 ·Status: COMPLETED ·Phase: NA
-
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
NCT01172002 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)
NCT00298506 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis
NCT02081183 ·Status: TERMINATED ·Phase: PHASE3
-
Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
NCT01060410 ·Status: COMPLETED
-
The Effect of Calcitriol on Progress and Activity of Lupus Nephritis
NCT01863641 ·Status: UNKNOWN ·Phase: PHASE2
-
To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis
NCT00881309 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
NCT00404794 ·Status: COMPLETED ·Phase: PHASE3
-
Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis
NCT03920059 ·Status: TERMINATED ·Phase: PHASE4
-
Cyclophosphamide in Lupus Nephritis
NCT00441220 ·Status: UNKNOWN
-
Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
NCT02630628 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare
NCT00423098 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis
NCT04924296 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
NCT01042457 ·Status: COMPLETED ·Phase: PHASE3
-
Weaning of Immunosuppression in Nephritis of Lupus
NCT01284725 ·Status: COMPLETED ·Phase: PHASE3
-
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
NCT02435368 ·Status: UNKNOWN
-
A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
NCT07229742 ·Status: RECRUITING ·Phase: PHASE2